Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin
Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin Xiao-Nan Li 1 , 2 , 3 , Jun Song 1 , 2 , 3 , Lin Zhang 1 , 2 , Scott A. LeMaire 1 , 2 , Xiaoyang Hou 1 , 2 , 3 , Cheng Zhang 1 , 2 , 3 , Joseph S. Coselli 1 ,...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2009-10, Vol.58 (10), p.2246-2257 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2257 |
---|---|
container_issue | 10 |
container_start_page | 2246 |
container_title | Diabetes (New York, N.Y.) |
container_volume | 58 |
creator | Li, Xiao-Nan Song, Jun Zhang, Lin LeMaire, Scott A Hou, Xiaoyang Zhang, Cheng Coselli, Joseph S Chen, Li Wang, Xing Li Zhang, Yun Shen, Ying H |
description | Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating
Thioredoxin
Xiao-Nan Li 1 , 2 , 3 ,
Jun Song 1 , 2 , 3 ,
Lin Zhang 1 , 2 ,
Scott A. LeMaire 1 , 2 ,
Xiaoyang Hou 1 , 2 , 3 ,
Cheng Zhang 1 , 2 , 3 ,
Joseph S. Coselli 1 , 2 ,
Li Chen 3 ,
Xing Li Wang 1 , 2 ,
Yun Zhang 3 and
Ying H. Shen 1 , 2
1 Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas;
2 Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas;
3 Qilu Hospital, Shandong University, Jinan, Shandong, China.
Corresponding authors: Yun Zhang, zhangyun{at}sdu.edu.cn , and Ying H. Shen, hyshen{at}bcm.edu .
X.-N.L. and J.S. contributed equally to this study.
Abstract
OBJECTIVE Oxidative stress induced by free fatty acids contributes to the development of cardiovascular diseases in patients with metabolic
syndrome. Reducing oxidative stress may attenuate these pathogenic processes. Activation of AMP-activated protein kinase (AMPK)
has been reported to reduce intracellular reactive oxygen species (ROS) levels. The thioredoxin (Trx) system is a major antioxidant
system. In this study, we investigated the mechanisms involved in the AMPK-mediated regulation of Trx expression and the reduction
of intracellular ROS levels.
RESEARCH DESIGN AND METHODS We observed that activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) significantly reduced ROS levels
induced by palmitic acid in human aortic endothelial cells. Activation of AMPK increased expression of the antioxidant Trx,
which mediated the ROS reduction. RT-PCR showed that AMPK regulated Trx at the transcriptional level.
RESULTS Forkhead transcription factor 3 (FOXO3) was identified as the target transcription factor involved in the upregulation of
Trx expression. FOXO3 bound to the Trx promoter, recruited the histone acetylase p300 to the Trx promoter, and formed a transcription activator complex, which was enhanced by AICAR treatment. AMPK activated FOXO3 by promoting
its nuclear translocation. We further showed that AICAR injection increased the expression of Trx and decreased ROS production
in the aortic wall of ApoE−/− mice fed a high-fat diet.
CONCLUSIONS These results suggest that activation of the AMPK-FOXO3 pathway reduces ROS levels by inducing Trx expression. Thus, the
AMPK-FOXO3-Trx axis may be an important defense mechanism against excessive ROS production induce |
doi_str_mv | 10.2337/db08-1512 |
format | Article |
fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A209234965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A209234965</galeid><sourcerecordid>A209234965</sourcerecordid><originalsourceid>FETCH-LOGICAL-c680t-60e56f76290700a30543b83d9e7c96824f0e0890e5a24906e2f51457adfb08973</originalsourceid><addsrcrecordid>eNp9ksGO0zAQhiMEYsvCgRdAFpyQyOLYiRNfVqoqulQUdQW70t4s15kkXqVxsZ3d9sYbcOANeRIcWrFUqtAcPBp_83v0e6LoZYLPCKX5-3KJizjJEvIoGiWc8piS_OZxNMI4IXGS8_wkeubcLcaYhXganSQ844QlxSj6MVZe30mvTYdMhXwDaPz58lM8XdwsKLqUvrmXW_QFyl6BQ1Pp_RaNlS5_ff8564ZiiWadsiAdIN2F3FupoG37VtrQJgd1QIvNtoYOfV2D0kFmuUXXawt1gLzuanTVaGOhNBvdPY-eVLJ18GJ_nkbX0w9Xk4_xfHExm4znsWIF9jHDkLEqZ4TjHGNJcZbSZUFLDrnirCBphQEXPFCSpBwzIFWWpFkuyyp4xXN6Gp3vdNf9cgWlgmHwVqytXkm7FUZqcXjT6UbU5k6QPMOEsiDwei9gzbcenBe3prddmFmQhKVFnrIBerODatmC0F1lBntW2ikxJpgTmnKWBSo-QgXDIDxsOqh0KB_wZ0f4ECWstDra8PagITAeNr6WvXOiuJj_b5g9q0zbQg0ifMJkcVRbWeOcheqvhwkWw3aKYTvFsJ2BffWv6Q_kfh0D8G4HNLpu7rUFUWq5BA_uIcmKP8okZfQ3zlXssA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216487466</pqid></control><display><type>article</type><title>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Li, Xiao-Nan ; Song, Jun ; Zhang, Lin ; LeMaire, Scott A ; Hou, Xiaoyang ; Zhang, Cheng ; Coselli, Joseph S ; Chen, Li ; Wang, Xing Li ; Zhang, Yun ; Shen, Ying H</creator><creatorcontrib>Li, Xiao-Nan ; Song, Jun ; Zhang, Lin ; LeMaire, Scott A ; Hou, Xiaoyang ; Zhang, Cheng ; Coselli, Joseph S ; Chen, Li ; Wang, Xing Li ; Zhang, Yun ; Shen, Ying H</creatorcontrib><description>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating
Thioredoxin
Xiao-Nan Li 1 , 2 , 3 ,
Jun Song 1 , 2 , 3 ,
Lin Zhang 1 , 2 ,
Scott A. LeMaire 1 , 2 ,
Xiaoyang Hou 1 , 2 , 3 ,
Cheng Zhang 1 , 2 , 3 ,
Joseph S. Coselli 1 , 2 ,
Li Chen 3 ,
Xing Li Wang 1 , 2 ,
Yun Zhang 3 and
Ying H. Shen 1 , 2
1 Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas;
2 Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas;
3 Qilu Hospital, Shandong University, Jinan, Shandong, China.
Corresponding authors: Yun Zhang, zhangyun{at}sdu.edu.cn , and Ying H. Shen, hyshen{at}bcm.edu .
X.-N.L. and J.S. contributed equally to this study.
Abstract
OBJECTIVE Oxidative stress induced by free fatty acids contributes to the development of cardiovascular diseases in patients with metabolic
syndrome. Reducing oxidative stress may attenuate these pathogenic processes. Activation of AMP-activated protein kinase (AMPK)
has been reported to reduce intracellular reactive oxygen species (ROS) levels. The thioredoxin (Trx) system is a major antioxidant
system. In this study, we investigated the mechanisms involved in the AMPK-mediated regulation of Trx expression and the reduction
of intracellular ROS levels.
RESEARCH DESIGN AND METHODS We observed that activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) significantly reduced ROS levels
induced by palmitic acid in human aortic endothelial cells. Activation of AMPK increased expression of the antioxidant Trx,
which mediated the ROS reduction. RT-PCR showed that AMPK regulated Trx at the transcriptional level.
RESULTS Forkhead transcription factor 3 (FOXO3) was identified as the target transcription factor involved in the upregulation of
Trx expression. FOXO3 bound to the Trx promoter, recruited the histone acetylase p300 to the Trx promoter, and formed a transcription activator complex, which was enhanced by AICAR treatment. AMPK activated FOXO3 by promoting
its nuclear translocation. We further showed that AICAR injection increased the expression of Trx and decreased ROS production
in the aortic wall of ApoE−/− mice fed a high-fat diet.
CONCLUSIONS These results suggest that activation of the AMPK-FOXO3 pathway reduces ROS levels by inducing Trx expression. Thus, the
AMPK-FOXO3-Trx axis may be an important defense mechanism against excessive ROS production induced by metabolic stress and
could be a therapeutic target in treating cardiovascular diseases in metabolic syndrome.
Footnotes
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received October 31, 2008.
Accepted June 28, 2009.
© 2009 by the American Diabetes Association.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db08-1512</identifier><identifier>PMID: 19592618</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Aminoimidazole Carboxamide - analogs & derivatives ; Aminoimidazole Carboxamide - pharmacology ; AMP-Activated Protein Kinases - metabolism ; Animals ; Antioxidants ; Aorta ; Apolipoproteins E - deficiency ; Apolipoproteins E - genetics ; Cardiovascular diseases ; Cardiovascular system ; Care and treatment ; Causes of ; DNA Primers ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - metabolism ; Fatty acids ; Fatty Acids - pharmacology ; Forkhead Box Protein O3 ; Forkhead Transcription Factors - metabolism ; Genetic aspects ; Growth factors ; Humans ; Kinases ; Male ; Metabolic syndrome ; Mice ; Mice, Knockout ; Original ; Oxidative stress ; Palmitic Acid - pharmacology ; Physiological aspects ; Plasmids - drug effects ; Quantitative analysis ; Reactive Oxygen Species - metabolism ; Research design ; Reverse Transcriptase Polymerase Chain Reaction ; Ribonucleotides - pharmacology ; Risk factors ; RNA, Messenger - genetics ; RNA, Small Interfering - genetics ; Thioredoxin ; Thioredoxins ; Thioredoxins - genetics ; Transcription factors ; Up-Regulation</subject><ispartof>Diabetes (New York, N.Y.), 2009-10, Vol.58 (10), p.2246-2257</ispartof><rights>COPYRIGHT 2009 American Diabetes Association</rights><rights>Copyright American Diabetes Association Oct 2009</rights><rights>2009 by the American Diabetes Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c680t-60e56f76290700a30543b83d9e7c96824f0e0890e5a24906e2f51457adfb08973</citedby><cites>FETCH-LOGICAL-c680t-60e56f76290700a30543b83d9e7c96824f0e0890e5a24906e2f51457adfb08973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750236/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750236/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19592618$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Xiao-Nan</creatorcontrib><creatorcontrib>Song, Jun</creatorcontrib><creatorcontrib>Zhang, Lin</creatorcontrib><creatorcontrib>LeMaire, Scott A</creatorcontrib><creatorcontrib>Hou, Xiaoyang</creatorcontrib><creatorcontrib>Zhang, Cheng</creatorcontrib><creatorcontrib>Coselli, Joseph S</creatorcontrib><creatorcontrib>Chen, Li</creatorcontrib><creatorcontrib>Wang, Xing Li</creatorcontrib><creatorcontrib>Zhang, Yun</creatorcontrib><creatorcontrib>Shen, Ying H</creatorcontrib><title>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating
Thioredoxin
Xiao-Nan Li 1 , 2 , 3 ,
Jun Song 1 , 2 , 3 ,
Lin Zhang 1 , 2 ,
Scott A. LeMaire 1 , 2 ,
Xiaoyang Hou 1 , 2 , 3 ,
Cheng Zhang 1 , 2 , 3 ,
Joseph S. Coselli 1 , 2 ,
Li Chen 3 ,
Xing Li Wang 1 , 2 ,
Yun Zhang 3 and
Ying H. Shen 1 , 2
1 Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas;
2 Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas;
3 Qilu Hospital, Shandong University, Jinan, Shandong, China.
Corresponding authors: Yun Zhang, zhangyun{at}sdu.edu.cn , and Ying H. Shen, hyshen{at}bcm.edu .
X.-N.L. and J.S. contributed equally to this study.
Abstract
OBJECTIVE Oxidative stress induced by free fatty acids contributes to the development of cardiovascular diseases in patients with metabolic
syndrome. Reducing oxidative stress may attenuate these pathogenic processes. Activation of AMP-activated protein kinase (AMPK)
has been reported to reduce intracellular reactive oxygen species (ROS) levels. The thioredoxin (Trx) system is a major antioxidant
system. In this study, we investigated the mechanisms involved in the AMPK-mediated regulation of Trx expression and the reduction
of intracellular ROS levels.
RESEARCH DESIGN AND METHODS We observed that activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) significantly reduced ROS levels
induced by palmitic acid in human aortic endothelial cells. Activation of AMPK increased expression of the antioxidant Trx,
which mediated the ROS reduction. RT-PCR showed that AMPK regulated Trx at the transcriptional level.
RESULTS Forkhead transcription factor 3 (FOXO3) was identified as the target transcription factor involved in the upregulation of
Trx expression. FOXO3 bound to the Trx promoter, recruited the histone acetylase p300 to the Trx promoter, and formed a transcription activator complex, which was enhanced by AICAR treatment. AMPK activated FOXO3 by promoting
its nuclear translocation. We further showed that AICAR injection increased the expression of Trx and decreased ROS production
in the aortic wall of ApoE−/− mice fed a high-fat diet.
CONCLUSIONS These results suggest that activation of the AMPK-FOXO3 pathway reduces ROS levels by inducing Trx expression. Thus, the
AMPK-FOXO3-Trx axis may be an important defense mechanism against excessive ROS production induced by metabolic stress and
could be a therapeutic target in treating cardiovascular diseases in metabolic syndrome.
Footnotes
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received October 31, 2008.
Accepted June 28, 2009.
© 2009 by the American Diabetes Association.</description><subject>Aminoimidazole Carboxamide - analogs & derivatives</subject><subject>Aminoimidazole Carboxamide - pharmacology</subject><subject>AMP-Activated Protein Kinases - metabolism</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Aorta</subject><subject>Apolipoproteins E - deficiency</subject><subject>Apolipoproteins E - genetics</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular system</subject><subject>Care and treatment</subject><subject>Causes of</subject><subject>DNA Primers</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - metabolism</subject><subject>Fatty acids</subject><subject>Fatty Acids - pharmacology</subject><subject>Forkhead Box Protein O3</subject><subject>Forkhead Transcription Factors - metabolism</subject><subject>Genetic aspects</subject><subject>Growth factors</subject><subject>Humans</subject><subject>Kinases</subject><subject>Male</subject><subject>Metabolic syndrome</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Original</subject><subject>Oxidative stress</subject><subject>Palmitic Acid - pharmacology</subject><subject>Physiological aspects</subject><subject>Plasmids - drug effects</subject><subject>Quantitative analysis</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Research design</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Ribonucleotides - pharmacology</subject><subject>Risk factors</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Small Interfering - genetics</subject><subject>Thioredoxin</subject><subject>Thioredoxins</subject><subject>Thioredoxins - genetics</subject><subject>Transcription factors</subject><subject>Up-Regulation</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9ksGO0zAQhiMEYsvCgRdAFpyQyOLYiRNfVqoqulQUdQW70t4s15kkXqVxsZ3d9sYbcOANeRIcWrFUqtAcPBp_83v0e6LoZYLPCKX5-3KJizjJEvIoGiWc8piS_OZxNMI4IXGS8_wkeubcLcaYhXganSQ844QlxSj6MVZe30mvTYdMhXwDaPz58lM8XdwsKLqUvrmXW_QFyl6BQ1Pp_RaNlS5_ff8564ZiiWadsiAdIN2F3FupoG37VtrQJgd1QIvNtoYOfV2D0kFmuUXXawt1gLzuanTVaGOhNBvdPY-eVLJ18GJ_nkbX0w9Xk4_xfHExm4znsWIF9jHDkLEqZ4TjHGNJcZbSZUFLDrnirCBphQEXPFCSpBwzIFWWpFkuyyp4xXN6Gp3vdNf9cgWlgmHwVqytXkm7FUZqcXjT6UbU5k6QPMOEsiDwei9gzbcenBe3prddmFmQhKVFnrIBerODatmC0F1lBntW2ikxJpgTmnKWBSo-QgXDIDxsOqh0KB_wZ0f4ECWstDra8PagITAeNr6WvXOiuJj_b5g9q0zbQg0ifMJkcVRbWeOcheqvhwkWw3aKYTvFsJ2BffWv6Q_kfh0D8G4HNLpu7rUFUWq5BA_uIcmKP8okZfQ3zlXssA</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Li, Xiao-Nan</creator><creator>Song, Jun</creator><creator>Zhang, Lin</creator><creator>LeMaire, Scott A</creator><creator>Hou, Xiaoyang</creator><creator>Zhang, Cheng</creator><creator>Coselli, Joseph S</creator><creator>Chen, Li</creator><creator>Wang, Xing Li</creator><creator>Zhang, Yun</creator><creator>Shen, Ying H</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>5PM</scope></search><sort><creationdate>20091001</creationdate><title>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin</title><author>Li, Xiao-Nan ; Song, Jun ; Zhang, Lin ; LeMaire, Scott A ; Hou, Xiaoyang ; Zhang, Cheng ; Coselli, Joseph S ; Chen, Li ; Wang, Xing Li ; Zhang, Yun ; Shen, Ying H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c680t-60e56f76290700a30543b83d9e7c96824f0e0890e5a24906e2f51457adfb08973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Aminoimidazole Carboxamide - analogs & derivatives</topic><topic>Aminoimidazole Carboxamide - pharmacology</topic><topic>AMP-Activated Protein Kinases - metabolism</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Aorta</topic><topic>Apolipoproteins E - deficiency</topic><topic>Apolipoproteins E - genetics</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular system</topic><topic>Care and treatment</topic><topic>Causes of</topic><topic>DNA Primers</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - metabolism</topic><topic>Fatty acids</topic><topic>Fatty Acids - pharmacology</topic><topic>Forkhead Box Protein O3</topic><topic>Forkhead Transcription Factors - metabolism</topic><topic>Genetic aspects</topic><topic>Growth factors</topic><topic>Humans</topic><topic>Kinases</topic><topic>Male</topic><topic>Metabolic syndrome</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Original</topic><topic>Oxidative stress</topic><topic>Palmitic Acid - pharmacology</topic><topic>Physiological aspects</topic><topic>Plasmids - drug effects</topic><topic>Quantitative analysis</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Research design</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Ribonucleotides - pharmacology</topic><topic>Risk factors</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Small Interfering - genetics</topic><topic>Thioredoxin</topic><topic>Thioredoxins</topic><topic>Thioredoxins - genetics</topic><topic>Transcription factors</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Xiao-Nan</creatorcontrib><creatorcontrib>Song, Jun</creatorcontrib><creatorcontrib>Zhang, Lin</creatorcontrib><creatorcontrib>LeMaire, Scott A</creatorcontrib><creatorcontrib>Hou, Xiaoyang</creatorcontrib><creatorcontrib>Zhang, Cheng</creatorcontrib><creatorcontrib>Coselli, Joseph S</creatorcontrib><creatorcontrib>Chen, Li</creatorcontrib><creatorcontrib>Wang, Xing Li</creatorcontrib><creatorcontrib>Zhang, Yun</creatorcontrib><creatorcontrib>Shen, Ying H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Xiao-Nan</au><au>Song, Jun</au><au>Zhang, Lin</au><au>LeMaire, Scott A</au><au>Hou, Xiaoyang</au><au>Zhang, Cheng</au><au>Coselli, Joseph S</au><au>Chen, Li</au><au>Wang, Xing Li</au><au>Zhang, Yun</au><au>Shen, Ying H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>58</volume><issue>10</issue><spage>2246</spage><epage>2257</epage><pages>2246-2257</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating
Thioredoxin
Xiao-Nan Li 1 , 2 , 3 ,
Jun Song 1 , 2 , 3 ,
Lin Zhang 1 , 2 ,
Scott A. LeMaire 1 , 2 ,
Xiaoyang Hou 1 , 2 , 3 ,
Cheng Zhang 1 , 2 , 3 ,
Joseph S. Coselli 1 , 2 ,
Li Chen 3 ,
Xing Li Wang 1 , 2 ,
Yun Zhang 3 and
Ying H. Shen 1 , 2
1 Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas;
2 Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas;
3 Qilu Hospital, Shandong University, Jinan, Shandong, China.
Corresponding authors: Yun Zhang, zhangyun{at}sdu.edu.cn , and Ying H. Shen, hyshen{at}bcm.edu .
X.-N.L. and J.S. contributed equally to this study.
Abstract
OBJECTIVE Oxidative stress induced by free fatty acids contributes to the development of cardiovascular diseases in patients with metabolic
syndrome. Reducing oxidative stress may attenuate these pathogenic processes. Activation of AMP-activated protein kinase (AMPK)
has been reported to reduce intracellular reactive oxygen species (ROS) levels. The thioredoxin (Trx) system is a major antioxidant
system. In this study, we investigated the mechanisms involved in the AMPK-mediated regulation of Trx expression and the reduction
of intracellular ROS levels.
RESEARCH DESIGN AND METHODS We observed that activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) significantly reduced ROS levels
induced by palmitic acid in human aortic endothelial cells. Activation of AMPK increased expression of the antioxidant Trx,
which mediated the ROS reduction. RT-PCR showed that AMPK regulated Trx at the transcriptional level.
RESULTS Forkhead transcription factor 3 (FOXO3) was identified as the target transcription factor involved in the upregulation of
Trx expression. FOXO3 bound to the Trx promoter, recruited the histone acetylase p300 to the Trx promoter, and formed a transcription activator complex, which was enhanced by AICAR treatment. AMPK activated FOXO3 by promoting
its nuclear translocation. We further showed that AICAR injection increased the expression of Trx and decreased ROS production
in the aortic wall of ApoE−/− mice fed a high-fat diet.
CONCLUSIONS These results suggest that activation of the AMPK-FOXO3 pathway reduces ROS levels by inducing Trx expression. Thus, the
AMPK-FOXO3-Trx axis may be an important defense mechanism against excessive ROS production induced by metabolic stress and
could be a therapeutic target in treating cardiovascular diseases in metabolic syndrome.
Footnotes
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received October 31, 2008.
Accepted June 28, 2009.
© 2009 by the American Diabetes Association.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>19592618</pmid><doi>10.2337/db08-1512</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-1797 |
ispartof | Diabetes (New York, N.Y.), 2009-10, Vol.58 (10), p.2246-2257 |
issn | 0012-1797 1939-327X |
language | eng |
recordid | cdi_gale_infotracmisc_A209234965 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Aminoimidazole Carboxamide - analogs & derivatives Aminoimidazole Carboxamide - pharmacology AMP-Activated Protein Kinases - metabolism Animals Antioxidants Aorta Apolipoproteins E - deficiency Apolipoproteins E - genetics Cardiovascular diseases Cardiovascular system Care and treatment Causes of DNA Primers Endothelium, Vascular - drug effects Endothelium, Vascular - metabolism Fatty acids Fatty Acids - pharmacology Forkhead Box Protein O3 Forkhead Transcription Factors - metabolism Genetic aspects Growth factors Humans Kinases Male Metabolic syndrome Mice Mice, Knockout Original Oxidative stress Palmitic Acid - pharmacology Physiological aspects Plasmids - drug effects Quantitative analysis Reactive Oxygen Species - metabolism Research design Reverse Transcriptase Polymerase Chain Reaction Ribonucleotides - pharmacology Risk factors RNA, Messenger - genetics RNA, Small Interfering - genetics Thioredoxin Thioredoxins Thioredoxins - genetics Transcription factors Up-Regulation |
title | Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T06%3A17%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20the%20AMPK-FOXO3%20Pathway%20Reduces%20Fatty%20Acid%E2%80%93Induced%20Increase%20in%20Intracellular%20Reactive%20Oxygen%20Species%20by%20Upregulating%20Thioredoxin&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=Li,%20Xiao-Nan&rft.date=2009-10-01&rft.volume=58&rft.issue=10&rft.spage=2246&rft.epage=2257&rft.pages=2246-2257&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/db08-1512&rft_dat=%3Cgale_cross%3EA209234965%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216487466&rft_id=info:pmid/19592618&rft_galeid=A209234965&rfr_iscdi=true |